Through the risk evaluation established by multivariate Cox regression model, we stratified ccRCC, bladder cancer (BC) and endometrial cancer (EC) patients into high and low PVT1-FAM193B groups (Figure 8A–8C). The gene discussed is PVT1; the disease is urinary bladder carcinoma.